Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hao-Ming Lin

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|April 9, 2008
[The human-mouse chimera nude mouse model set up from umbilical cord blood transplantation]Tao Huang, Bo Li, Hao-ming Lin, et al.
World Journal of Gastroenterology|October 31, 2014
Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinomaHao-Ming Lin, Li-Ming Lei, Jie Zhu, et al.
Frontiers in Oncology|April 4, 2022
Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature ReviewQin-Qin Liu, Hao-Ming Lin, Hong-Wei Han, et al.
World Journal of Clinical Cases|August 9, 2021
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reportsShao-Ru Liu, Qing Yan, Hao-Ming Lin, et al.
Science China. Life Sciences|July 20, 2019
Clinical strategies for differentiating IgG4-related cholecystitis from gallbladder carcinoma to avoid unnecessary surgical resectionRui Zhang, Hao-Ming Lin, Zhao-Xi Cai, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinomaWei Chen, Ming-Juan Hu, Xiao-Lan Zhong, et al.
Signal Transduction and Targeted Therapy|December 17, 2019
Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathwayRui Zhang, Hao-Ming Lin, Ruth Broering, et al.
Signal Transduction and Targeted Therapy|May 5, 2023
Retraction Note: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathwayRui Zhang, Hao-Ming Lin, Ruth Broering, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 15, 2024
Pure laparoscopic full-size liver transplantation in adultWen-Rui Wu, Lei-Bo Xu, Fa-Peng Zhang, et al.
World Journal of Surgical Oncology|February 28, 2025
Efficacy and conversion outcome of chemotherapy combined with PD-1 inhibitor for patients with unresectable or recurrent gallbladder carcinoma: a real-world exploratory studyQin-Qin Liu, Jian Yan, Yan-Fang Ye, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|April 9, 2008
[The human-mouse chimera nude mouse model set up from umbilical cord blood transplantation]Tao Huang, Bo Li, Hao-ming Lin, et al.
World Journal of Gastroenterology|October 31, 2014
Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinomaHao-Ming Lin, Li-Ming Lei, Jie Zhu, et al.
Frontiers in Oncology|April 4, 2022
Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature ReviewQin-Qin Liu, Hao-Ming Lin, Hong-Wei Han, et al.
World Journal of Clinical Cases|August 9, 2021
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reportsShao-Ru Liu, Qing Yan, Hao-Ming Lin, et al.
Science China. Life Sciences|July 20, 2019
Clinical strategies for differentiating IgG4-related cholecystitis from gallbladder carcinoma to avoid unnecessary surgical resectionRui Zhang, Hao-Ming Lin, Zhao-Xi Cai, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinomaWei Chen, Ming-Juan Hu, Xiao-Lan Zhong, et al.
Signal Transduction and Targeted Therapy|December 17, 2019
Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathwayRui Zhang, Hao-Ming Lin, Ruth Broering, et al.
Signal Transduction and Targeted Therapy|May 5, 2023
Retraction Note: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathwayRui Zhang, Hao-Ming Lin, Ruth Broering, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 15, 2024
Pure laparoscopic full-size liver transplantation in adultWen-Rui Wu, Lei-Bo Xu, Fa-Peng Zhang, et al.
World Journal of Surgical Oncology|February 28, 2025
Efficacy and conversion outcome of chemotherapy combined with PD-1 inhibitor for patients with unresectable or recurrent gallbladder carcinoma: a real-world exploratory studyQin-Qin Liu, Jian Yan, Yan-Fang Ye, et al.
Pageof 3